WHAT: Some of the nation’s top health care CEOs discuss reimagining the global pharmaceutical supply chain. The live webinar series will highlight drug executives’ thoughts and strategies for addressing the challenges industries face in the COVID-19 era. PCMA will host
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on a new advertising campaign against Section 306 in S. 1895, the “Lower Health Care Costs Act:”
Conversation on “Improving Competition to Lower Drug Prices” Emphasizes Need to Stop Abuse of the Patent System Last week, The Hill hosted an event titled, “Prescription for Change: Improving Competition to Lower Drug Prices.” During the event, lawmakers and a panel of drug
Lawmakers Reintroduce Bill to Close Loopholes Allowing Big Drug Companies to Block Competition from More Affordable Options The Pharmaceutical Care Management Association, PCMA, applauds Senators Maggie Hassan (D-NH) and Mike Braun (R-IN) for recently reintroducing legislation, the Prescription Drug Competition Act,
©2024 PCMA. All Rights Reserved.
